mefloquine has been researched along with Bilharziasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arango, D; Bottieau, E; Brosius, I; Burm, C; Cisse, B; De Hondt, A; Faye, BT; Mboup, S; Mbow, M; Paredis, L; Polman, K; Potters, I; Roucher, C; Smekens, B; Tsoumanis, A; van Herrewege, Y | 1 |
| Chiodini, J; Chiodini, P | 1 |
1 review(s) available for mefloquine and Bilharziasis
| Article | Year |
|---|---|
Key developments in travel medicine.
Topics: Animals; Antimalarials; Culicidae; Dengue; Hematuria; Humans; Malaria; Mefloquine; Schistosomiasis; Seizures, Febrile; Travel | 1998 |
1 trial(s) available for mefloquine and Bilharziasis
| Article | Year |
|---|---|
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial.
Topics: Anthelmintics; Artesunate; Child; Humans; Mefloquine; Randomized Controlled Trials as Topic; Schistosomiasis; Senegal; Treatment Outcome | 2021 |